Sofinnova Investments’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Sofinnova Investments’s Portfolio CINC Stock Details CINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-6,073,949	Closed	-$74.6M	–	65
2022 Q4	$74.6M	Sell	6,073,949 -6,000	-0.1%	-$143K	4.43%	6
2022 Q3	$200M	Buy	6,079,949 +506,000	+9%	+$14.3M	11.61%	2
2022 Q2	$105M	Hold	5,573,949	–	–	8.75%	3
2022 Q1	$97.8M	Buy	+5,573,949	New	+$114M	7.42%	3

Sofinnova Investments's CINC Position: Q1 2023 in Review

Sofinnova Investments sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 6,073,949 shares — an estimated $74.6M sold.

Sofinnova Investments first reported a position in CINC in Q1 2022 and held it in 4 quarters. The position peaked at $200M in Q3 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

Sofinnova Investments reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Sofinnova Investments sold 6,073,949 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $74.6M.
Sofinnova Investments first reported a position in CinCor Pharma, Inc. Common Stock in Q1 2022 and held it in 4 quarters.
Sofinnova Investments's CinCor Pharma, Inc. Common Stock position peaked at $200M in Q3 2022.
0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on Sofinnova Investments's 13F filing for Q1 2023, filed 11 May 2023.